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The 825T allele of the G-protein b3-subunit is associated
with increased intracellular signalling. Its association
with hypertension is inconsistent. We, therefore, studied
the C825T polymorphism in relation to ambulatory blood
pressure as well as left ventricular structure and
function in two European populations. We genotyped
248 parents and 318 offspring, enrolled in the European
Project on Genes in Hypertension in Cracow, Poland
(n¼ 286) and in Novosibirsk, Russian Federation
(n¼ 280). The 24-h ambulatory blood pressure was
recorded using oscillometric SpaceLabs 90207 moni-
tors. Within each centre, a single observer performed
two-dimensionally guided M-mode echocardiography
and Doppler sonography to measure left ventricular
structure (American Society of Echocardiography con-
ventions) and diastolic function: early (E) and late (A)
peak diastolic inflow velocities. We used analysis of
covariance and generalized estimating equations to
allow for covariables and nonindependence among
related subjects. Genotype frequencies were similar
(P¼ 0.25) in Cracow and Novosibirsk and amounted to
44.7% for CC, 47.2% for CT, and 8.1% for TT. Among
parents (mean age: 51.3 years)Fbut not among off-
spring (mean age 25.1 years)F24-h, daytime and night
time systolic blood pressures were 5–6 mmHg higher in
TT homozygotes than in C allele carriers. In TT
homozygous parents (8.2 cm/sec, P¼ 0.004) as well
as in TT homozygous offspring (7.5 cm/sec, P¼ 0.02),
the E-wave was significantly reduced, which in offspring
also resulted in a lower E/A ratio (–0.25, P¼ 0.002).
Neither in parents nor in offspring, left ventricular mass
index was associated with the C825T polymorphism. In
conclusion, in TT homozygotes of both generations,
early left ventricular relaxation was reduced. In TT
homozygous parents, the latter observation might be
because of the higher systolic pressure associated with
the TT genotype.
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Introduction
Guanine nucleotide regulatory proteins (G-proteins)
are part of many intracellular signalling cascades. 1
Their activation is the principal mechanism through
which stimulated heptahelical receptors generate
changes in intracellular function.1 Siffert et al2
identified a common C825T polymorphism in exon
10 of the b3-subunit of the heterotrimeric G-protein.
The 825T allele has been associated with a splice
variant, which shortens the protein by 41 amino
acids. This mutation leads to a gain in function2 and
entails stimulation of the ubiquitously expressed
Na+/H+ exchanger.3,4 de la Sierra et al5 observed
that in patients with essential hypertension, left
ventricular hypertrophy was associated with in-
creased Na+/H+ exchanger activity. In addition,
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several studies6–8 reported that disorders such as
obesity and hypertension, which may cause left
ventricular hypertrophy, are associated with the G-
protein b3-subunit (GNB3) gene C825T polymorph-
ism. We, therefore, investigated the possible impact
of this genetic polymorphism on ambulatory blood
pressure as well as left ventricular structure and
function in White Europeans.
Methods
General outline of the study
The primary goal of the European Project on Genes
in Hypertension (EPOGH) Study was to investigate
the complex relation between blood pressure ana-
lysed as a continuous or binary phenotype
and various candidate genes.9 In addition to blood
pressure, several other intermediate or associated
phenotypes, such as left ventricular mass were
measured. The epidemiological methods used in
EPOGH have been previously validated.9–11 The
project was conducted according to the principles
outlined in the Helsinki declaration for investiga-
tions in human subjects.12 Each local Institutional
Review Board approved the study. Participants gave
informed written consent.
Study population
Nuclear families were recruited in seven countries
(Belgium, Bulgaria, the Czech Republic, Italy,
Poland, Romania, and the Russian Federation).9
Families had to include at least one parent and
two siblings. The age range for participation was
18–60 years. For the present analysis, the study
population was limited to 631 subjects recruited by
the two centres that, at the time of writing of this
manuscript, had participated in the optional sub-
study on echocardiography: Cracow (Poland, Centre
1) and Novosibirsk (the Russian Federation, Centre
2). Subjects were not considered for analysis (1) if
they had declined the invitation for the echocardio-
graphic examination (n¼ 49), (2) if the echocardio-
gram was of bad quality (n¼ 7), (3) if the subjects
had impairment of left ventricular systolic function
(n¼ 3), or a valvular disorder (n¼ 1), or (4) if their
DNA did not amplify (n¼ 5).
Trained observers measured blood pressure five
times consecutively during each of two home visits
after the subjects had rested for 5 min in the sitting
position. The guidelines of the British Society of
Hypertension were applied.13 Each subject’s con-
ventional blood pressure was the mean of five
consecutive readings obtained at the second contact
with the subject.9 Hypertension was diagnosed if the
average of the five readings was at least 140 mmHg
systolic or 90 mmHg diastolic, or when the subjects
were on antihypertensive drug treatment.
Validated oscillometric SpaceLabs 90207 moni-
tors (Redmond, WA, USA) fitted with the same cuff
size as for conventional measurements were pro-
grammed to obtain readings with an interval of
15 min from 08:00 to 22:00 h and every 30 min from
22:00 to 08:00 h. In keeping with current recom-
mendations,14 daytime was defined as the interval
from 10:00 to 22:00 h and night time from midnight
to 06:00 h. These definitions eliminate the transition
periods in the morning and evening, during which
rapid blood pressure changes occur in most subjects.
Via a standardized interview, information was
collected on each participant’s personal and familial
medical history, smoking and drinking habits,
physical activity, and use of medications. Body
surface area (BSA; m2) was calculated as body
weight (kg)0.425 body height (cm)0.725 71.84.15
Echocardiographic methods
In each centre, one experienced observer (AO and
AR) performed all echocardiograms, using a com-
mercially available ultrasonograph equipped with a
3.5-MHz. transducer with the subjects in left
decubitus position. M-mode echocardiograms of
the left ventricle were obtained at end-expiration
from the parasternal long-axis view under control of
the two-dimensional image. The ultrasound beam
was positioned just below the mitral valve at the
level of the posterior chordae tendineae. Left
ventricular internal dimension (LVID) and inter-
ventricular septal (IVST) and posterior wall thick-
ness (PWT) were measured at end-diastole
according to the recommendations of the American
Society of Echocardiography, using the leading
edge-to-leading edge convention.16,17 For statistical
analysis, the measurements of three cardiac cycles
were averaged. Studies were recorded on video-
tapes. End-diastolic left ventricular dimensions
were used to calculate left ventricular mass by an
anatomically validated formula.18 The relative wall
thickness was calculated as (IVST+PWT)/LVID. The
intraobserver intersession reproducibility coeffi-
cient for left ventricular mass was 2.5% for Centre
1 and 2.0% for Centre 2. Left ventricular mass index
was calculated as left ventricular mass divided by
BSA.18 As a measure of systolic function, dimen-
sional fractional shortening was computed.18 For
evaluation of diastolic function, mitral inflow
velocities were recorded with pulsed-wave Doppler
sonography. Pulsed Doppler spectral recordings
were obtained from the apical four-chamber view
with a sample volume positioned at the tips of the
mitral leaflets. Three consecutive cardiac cycles
were averaged to measure peak velocities reached
in early diastole (E-wave) and after atrial contraction
(A-wave),19 and to calculate the E/A ratio.
Determination of the genotype
Genomic DNA was extracted from white blood cells.
From the published DNA sequence of the GNB3,20
we amplified a 268 base pair fragment incorporating
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the polymorphic site with the use of two primers as
described by Siffert et al.21 We previously published
the technical procedures, which we implemented
for DNA amplification and determination of the
genotypes by allele-specific hybridization.22
Statistical analysis
We used the SAS software package, version 6.12
(SAS Institute, Cary, NC, USA) for database manage-
ment and statistical analysis. Comparisons of means
and proportions involved the standard normal z-test
and the w2-statistic, respectively. Regression slopes
were compared using a multiple regression ap-
proach as described by Kleinbaum et al.23 We first
searched for possible confounders using stepwise
multiple regression with the P-value for covariables
to enter and stay in the model set at 0.15.
Continuous traits adjusted for covariables were
first analysed by analysis of covariance. Since
genetic heterogeneity among pathophysiologically
related phenotypes consistently suggested a reces-
sive pattern, we subsequently only compared TT
homozygotes with C allele carriers, using the least-
square mean option of the PROC GLM procedure.
Since family members are more likely to share
identical alleles than randomly selected subjects
and to allow for the nonindependence of the
cardiovascular phenotypes within families, we
repeated our analyses using generalized estimating
equations (GEE) as implemented in the PROC
GENMOD procedure of the SAS package.24 In GEE
analyses, we adjusted for confounders, we treated
families as clusters and family members as repeated
observations within clusters, and we defined the
working correlation matrix as unstructured.
Results
Characteristics of the study participants
Our study population (n¼ 566) included 248 par-
ents and 318 offspring. Their clinical, demographic
and echocardiographic characteristics are reported
in Table 1. Mean age (7 s.d.) was 51.375.3 years in
parents and 25.17 5.0 years in offspring. Body mass
index (28.774.9 vs 22.77 3.2 kg/m2), 24-h blood
pressure (124.5713.3/77.17 8.7 vs 116.07 8.9/
68.476.4 mmHg), and left ventricular mass index
(106.9725.5 vs 85.5717.4 g/m2) were higher in
parents than offspring (Po0.001 for all). The
prevalence of hypertension based on conventional
blood pressure measurement was higher in parents
than offspring (54.4 vs 10.4%, P¼ 0.001). Peak
early diastolic inflow velocity was lower in parents
than offspring (66.27 17.3 vs 85.17 15.3 cm/s;
Po0.001), whereas the opposite was observed for
peak late diastolic wave velocity (64.57 14.1 vs
51.1711.4 cm/s; Po0.001). As a consequence, the
E/A ratio was lower in parents than offspring
(1.067 0.32 vs 1.7270.41, Po0.001). A total of 56
parents (22.6%) were current smokers and 73
(29.4%) reported intake of alcohol (X5 g of ethanol
per day). Among offspring, these numbers were 99
(31.1%) and 115 (36.2%), respectively. Gender
differences showed similar trends in both genera-
tions and are reported in Table 1.
Genotype and allele frequencies
The genotype frequencies of the C825T polymorph-
ism did not significantly deviate from Hardy–
Weinberg equilibrium in Novosibirsk (P¼ 0.81) or
Cracow (P¼ 0.06). Genotype and allele frequencies
Table 1 General characteristics of offspring and parent generations
Sons Daughters Fathers Mothers
N=151 N=167 N=100 N=148
Clinical characteristics
Age (years) 24.5 (4.7) 25.6 (5.2) 52.0 (5.1) 50.9 (5.5)
Body mass index (kg/m2) 23.1 (3.0) 22.3 (3.4)* 27.3 (4.1) 29.6 (5.2)***
Systolic pressure (mmHg)a 124.5 (12.6) 111.5 (10.3)*** 134.3 (18.0) 136.4 (19.3)
Diastolic pressure (mmHg)a 77.1 (9.8) 71.4 (7.9) *** 86.8 (11.8) 86.7 (10.0)
Hypertension (n) 26 (17.2%) 7 (4.2%)*** 51 (51.0%) 85 (57.0%)
Hypertension treated (n) 10 (6.6%) 3 (1.8%) 21 (21.0%) 58 (39.2%) **
Echocardiographic measurements
Left ventricular mass (g) 178.5 (36.8) 130.5 (28.2)*** 227.1 (58.6) 181.9 (48.5)***
Left ventricular mass index (g/m2) 93.6 (16.8) 78.2 (14.4)*** 115.5 (25.5) 101.1 (23.9)***
Left ventricular mass/height 2.7 (g/m2.7) 37.7 (7.6) 33.8 (7.6)*** 51.7 (13.8) 50.9 (13.9)
Left ventricular fractional shortening (%) 38.4 (4.9) 39.6 (4.0)*** 38.0 (5.7) 41.1 (5.0)***
E-wave (cm/sec) 84.5 (16.1) 85.5 (14.7) 60.7 (15.1) 69.9 (17.8)***
A-wave (cm/sec) 50.2 (11.9) 51.8 (10.9) 62.3 (14.0) 65.9 (14.1)*
E/A ratio 1.74 (0.43) 1.70 (0.37) 1.00 (0.29) 1.10 (0.33)*
Heart rate (bpm)b 70.8 (11.4) 72.4 (10.0) 67.9 (12.1) 70.4 (9.8)
aAverage of five readings at the second contact with the subject.
bHeart rate during echocardiography.
Values are arithmetic means (s.d.), or number of subjects (%). Significance of the difference between men and women within each generation:
*Po0.05; **Po0.01; ***Po0.001.
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also did not differ according to the centre (Table 2),
or the presence vs the absence of hypertension
(P¼ 0.54).
Association analysis
Blood pressure on ambulatory measurement did
not differ across genotypes in offspring (PX0.16;.
Table 3). However, in parents (Table 4), the ANOVA
P-values for systolic pressure on 24-h, daytime and
night time ambulatory measurements were smaller
than 0.15. Since trends in the systolic measurements
consistently suggested a recessive effect of the T
allele, we subsequently compared TT homozygotes
with C allele carriers. TT homozygous parents had
higher 24-h, daytime and night time systolic
pressures (Table 4 and Figure 1; Pr0.04). Left
ventricular mass index, left ventricular mass/
height2.7, fractional shortening and heart rate mea-
sured during the echocardiographic examination
did not differ across genotypes in offspring
(PX0.41; Table 3) or parents (PX0.32; Table 4).
However, in both generations, there was a signifi-
cant association between peak early diastolic inflow
velocity and the GNB3 C825T polymorphism, which
in offspring also resulted in significant genetic
difference in the E/A ratio. Indeed, in both genera-
tions, peak early diastolic inflow velocity was
consistently lower in TT homozygotes than in C
allele carriers (Tables 3 and 4; Figure 1). Further
analyses of peak early diastolic inflow velocity and
the E/A ratio did not show a significant gender-by-
genotype interaction in either generation (PX0.27)
or a significant generation-by-genotype interaction
in either sex (PX0.10; Figure 2). Overall, for two
generations and both sexes combined, TT homo-
zygotes compared to C allele carriers had signifi-
cantly lower peak early diastolic inflow velocity
(69.77 13.4 vs 77.5713.1 cm/sec) and E/A ratio
(1.297 0.33 vs 1.457 0.32; Figure 2).
We repeated our analyses with a similar set of
covariables as above using GEE instead of analysis of
covariance to allow for the nonindependence of the
phenotypes within families. The GEE analyses
confirmed ANOVA results.
In all subjects combined, the E/A ratio decreased
with increasing systolic blood pressure (–0.0023 per
mmHg; P¼ 0.02). Furthermore, neither in offspring
Table 2 Genotype and allele frequencies by centre
Genotypes Alleles
CC CT TT C T
Cracow 124 (43.4%) 143 (50.0%) 19 (6.6%) 391 (68.4%) 181 (31.6%)
Novosibirsk 129 (46.1%) 124 (44.3%) 27 (9.6%) 382 (68.2%) 178 (31.8%)
Total 253 (44.7%) 267 (47.2%) 46 (8.1%) 773 (68.3%) 359 (31.7%)
P-values for between-centre difference in genotype and allele frequencies were 0.25 and >0.99, respectively.
Table 3 Phenotypes by G-protein b3-subunit genotypes in offspring
Genotypes statistics PANOVA P (TT vs CC+CT)
CC CT TT
n=144 n=153 n=21
Clinical measurements
24-h systolic pressure (mmHg) 116.5 (0.6) 115.7 (0.6) 115.0 (1.6) 0.55 F
24-h diastolic pressure (mmHg) 68.8 (0.5) 68.2 (0.5) 67.6 (1.3) 0.58 F
Daytime systolic pressure (mmHg) 123.4 (0.7) 123.0 (0.7) 122.4 (1.8) 0.85 F
Daytime diastolic pressure (mmHg) 75.3 (0.6) 74.9 (0.6) 74.1 (1.5) 0.75 F
Night time systolic pressure (mmHg) 105.8 (0.7) 104.2 (0.7) 103.3 (1.8) 0.16 F
Night time diastolic pressure (mmHg) 58.6 (0.5) 57.7 (0.5) 57.3 (1.4) 0.38 F
Echocardiographic data
Left ventricular mass index (g/m2) 85.1 (1.3) 85.7 (1.2) 87.3 (3.4) 0.81 F
E-wave (cm/sec) 85.9 (1.1) 85.2 (1.1) 78.2 (2.9) 0.05 0.02
A-wave (cm/sec) 50.6 (0.8) 51.2 (0.8) 53.1 (2.1) 0.55 F
E/A ratio 1.75 (0.03) 1.73 (0.03) 1.49 (0.08) 0.008 0.002
Values are means (s.e.) adjusted for centre, sex and age. For blood pressure additional covariables accounted for in the analysis were body mass
index and use of antihypertensive medication. For left ventricular mass index, additional covariables were systolic blood pressure and use of
antihypertensive medication, and for left ventricular Doppler measurements also heart rate.
TT homozygotes and C allele carriers were compared, if the ANOVA P-value was p0.15.
G-protein associated with cardiovascular phenotypes
A Olszanecka et al
328
Journal of Human Hypertension
(P¼ 0.62) nor in parents (P¼ 0.30), the slope of the
E/A ratio on systolic blood pressure differed
between TT homozygotes and C allele carriers.
Discussion
We studied phenotypic variation associated with the
GNB3 C825T polymorphism in two European
populations. Our main finding was that left ven-
tricular relaxation, as reflected by peak early
diastolic inflow velocity, was reduced in TT
homozygotes of both the parent and the offspring
generation. Moreover, in TT homozygous parents,
systolic blood pressure measured by ambulatory
monitoring was approximately 5 mmHg higher than
in C allele carriers. Only one small study in 34
white patients with essential hypertension found a
Table 4 Phenotypes by G-protein b3-subunit genotypes in parents
Genotypes statistics PANOVA P (TT vs CC+CT)
CC CT TT
n=109 n=114 n=25
Clinical measurements
24-h systolic pressure (mmHg) 124.0 (1.2) 124.0 (1.1) 129.5 (2.4) 0.10 0.03
24-h diastolic pressure (mmHg) 76.8 (0.8) 76.9 (0.8) 79.1 (1.7) 0.43 F
Daytime systolic pressure (mmHg) 129.6 (1.2) 129.5 (1.2) 135.0 (2.5) 0.13 0.04
Daytime diastolic pressure (mmHg) 81.9 (0.8) 81.9 (0.8) 83.8 (1.8) 0.59 F
Night time systolic pressure (mmHg) 113.1 (1.2) 114.3 (1.2) 119.6 (2.6) 0.08 0.03
Night time diastolic pressure (mmHg) 67.8 (0.9) 68.6 (0.8) 70.8 (1.8) 0.29 F
Echocardiographic data
Left ventricular mass index (g/m2) 107.9 (2.1) 105.0 (2.0) 111.6 (4.3) 0.32 F
E-wave (cm/sec) 67.3 (1.3) 66.8 (1.3) 58.9 (2.7) 0.02 0.004
A-wave (cm/sec) 64.3 (1.2) 64.6 (1.1) 64.1 (2.4) 0.96 F
E/A ratio 1.08 (0.03) 1.06 (0.03) 0.99 (0.05) 0.25 F
For explanation, see Table 3.
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reduced transmitral blood flow in relation to the
GNB3 825T allele.25 Two other reports involving
hypertensive patients with and without left ventri-
cular hypertrophy demonstrated a positive associa-
tion between left ventricular mass and the 825T
allele.26,27 In contrast, a large population-based
study did not reveal any association between
cardiac structure and GNB3 T allele.28
Association never proves causation. Nevertheless,
several mechanisms may explain why early left
ventricular relaxation may be impaired in the
presence of the 825T allele. First, in TT homozygous
parents we observed a 5 mmHg higher systolic
pressure throughout the whole day. Impaired left
ventricular diastolic filling is an early marker of
hypertensive heart disease and precedes the struc-
tural adaptation of the myocardium to high blood
pressure.29 However, this mechanism is unlikely to
account fully for the reduced early diastolic filling
in TT homozygous offspring, because among sib-
lings the ambulatory blood pressure was similar
across genotypes. Age is also an important deter-
minant of left ventricular structure and function.
However, the relative decrease in peak early dia-
stolic inflow velocity in TT homozygotes compared
to C allele carriers was similar in offspring and
parents, averaging approximately 10%. Further-
more, neither in offspring nor in parents, the slope
of the E/A ratio on systolic blood pressure differed
between TT homozygotes and C allele carriers.
In addition to blood pressure, age and their
interaction, molecular mechanisms may also ex-
plain our findings. In cardiomyocytes, the extrusion
and sequestration of free calcium during diastole
is dependent on cyclic AMP, is modulated by
b-receptors, and is influenced by several ion transport
mechanisms including the Na+/H+ exchanger.30–36
Cardiac b-receptors couple to a G-protein-stimulated
adenylcyclase, which in turn stimulates cyclic
AMP-dependent regulatory mechanisms.30,31,33,37
Recent studies in rodent cardiomyocytes revealed
that b2-receptors couple to G-proteins, which lead to
inhibition of cyclic AMP formation downstream.38,39
In the ischaemic myocardium, the Na+/H+ exchan-
ger, which itself is under the influence of the C825T
polymorphism,3,4 exerts an important modulatory
action on cardiac excitation–contraction coupling.36
Published studies on the possible influence of the
GNB3 C825T polymorphism reported inconsistent
results. The 825T allele was associated with in-
creased blood pressure40–42 or increased risk of
hypertension22,43,44 in Germans,22,39,42,44 Australian
White hypertensive patients41 and Caribbean or
West African Blacks,43 but not in French,22 Irish,22
Japanese45,46 or African Americans.47 These discor-
dant findings suggest that ethnic or genetic back-
ground,8 lifestyle or various environmental factors
may modulate the potential effect of the C825T allele
on blood pressure. The frequency of the T allele was
0.32 in our Caucasian populations, but it is
approximately 0.50 in Japanese45,46 or native Amer-
icans48,49 and 0.7542,46 in black populations. One
possible mechanism for the higher systolic blood
pressure might be chronic sodium retention and
expansion of the circulating volume as a conse-
quence of the higher activity of the Na+/H+ exchan-
ger.2,4 Several observations support this hypothesis.
In one population-based study, plasma renin activ-
ity was decreased in the presence of the T allele.40
Turner et al49 found in black and non-Hispanic
white populations with essential hypertension that
systolic and diastolic blood pressure declined 5–
6 mmHg more in response to diuretic treatment in
TT than CC homozygotes. Zeltner et al3 found in
young men with normotension or mild incipient
essential hypertension (mean age 26 years) that
carriers of the 825T allele had faster tubular sodium
reabsorption than CC homozygotes. However, in the
present study, end-diastolic left ventricular diameter
did not increase with the number of T alleles as one
might expect in the case of a volume-dependent rise
in systolic pressure. Discordance among the pub-
lished reports on hypertension in relation to the
C825T polymorphism22,23,40–47 might also be because
of the large variability in the blood pressure
phenotype. Indeed, in most studies it was only
measured on a single occasion by conventional
sphygmomanometry.
In conclusion, in TT homozygotes compared to C
allele carriers, left ventricular relaxation, as re-
flected by the early peak diastolic inflow velocity,
was reduced. In TT homozygous parents, this
observation may be because of the higher systolic
pressure associated with this genotype.
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